Evidence that sleep deprivation down regulates dopamine D2R in ventral striatum in the human brain

Journal of Neuroscience

Volumn 32, Issue 19, 2012, Pages 6711-6717

  Volkow, Nora D ^a,b   Tomasi, Dardo ^c   Wang, Gene Jack ^c   Telang, Frank ^b   Fowler, Joanna S ^c   Logan, Jean ^c   Benveniste, Helene ^d   Kim, Ron ^b   Thanos, Panayotis K ^b   Ferré, Sergi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; METHYLPHENIDATE; PLACEBO; RACLOPRIDE C 11;

ADULT; AGE; ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; MICRODIALYSIS; NONHUMAN; NORMAL HUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; SLEEP DEPRIVATION; SOMNOLENCE; WAKEFULNESS;

ADULT; ANIMALS; BASAL GANGLIA; BRAIN; DOWN-REGULATION; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SLEEP DEPRIVATION; WAKEFULNESS; YOUNG ADULT;

EID: 84860672209     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0045-12.2012     Document Type: Article

References (59)

1. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58:1019-1024.
2. Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Goodman and Gilmans's the pharmacological basis of therapeutics (Goodman Gilman AG, Rail TW, Nies AS, Taylor P, eds), pp 447-484. New York: Pergamon.
3. Bartlett SE, Enquist J, Hopf FW, Lee JH, Gladher F, Kharazia V, Waldhoer M, Mailliard WS, Armstrong R, Bonci A, Whistler JL (2005) Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A 102:11521-11526.
4. Biaggioni I, Paul S, Puckett A, Arzubiaga C (1991) Caffeine and theophyl-line as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 258:588-593.
5. Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Ciruela F, Agnati LF, Fuxe K (2011) On the existence of a possible A2A-D2-beta-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced beta-arrestin2 recruitment. J Mol Biol 406:687-699.
6. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accum-bens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267-1270.
7. Dassesse D, Massie A, Ferrari R, Ledent C, Parmentier M, Arckens L, Zoli M, Schiffmann SN (2001) Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors. J Neurochem 78:183-198.
8. Durmer JS, Dinges DF (2005) Neurocognitive consequences of sleep deprivation. Semin Neurol 25:117-129.
9. Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A (2007) Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J Neurosci 27:2410-2415.
10. Elmenhorst D, Basheer R, McCarley RW, Bauer A (2009) Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res 1258:53-58.
11. Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, Quiroz C, Justinova Z, Lluis C, Franco R, Goldberg SR (2008) Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci 13:2391-2399.
12. Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, Turner R (1995) Analysis of fMRI time-series revisited. Neuroimage 2:45-53.
13. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144.
14. Gillin JC (1998) Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 393:39-43.
15. Ginovart N, Wilson AA, Houle S, Kapur S (2004) Amphetamine pretreat-ment inducesa changein both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats. Biol Psychiatry 55:1188-1194.
16. Hayaishi O, Urade Y, Eguchi N, Huang ZL (2004) Genes for prostaglandin d synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep. Arch Ital Biol 142:533-539.
17. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K (2002) Coaggregation, cointernaliza-tion, and codesensitizationof adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091-18097.
18. Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y, Hayaishi O (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8:858-859.
19. Huff JK, Davies MI (2002) Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J Pharm Biomed Anal 29:767-777.
20. Iizuka Y, Sei Y, Weinberger DR, Straub RE (2007) Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 27:12390-12395.
21. Kaasinen V, Aalto S, Någren K, Rinne JO (2004) Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15:281-285.
22. Killgore WD, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ (2008)Effects of dextroamphetamine, caffeine and modafinil on psy- chomotor vigilance test performance after 44 h of continuous wakeful- ness. J Sleep Res 17:309-321.
23. Kitka T, Katai Z, Pap D, Molnar E, Adori C, Bagdy G (2009) Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound. Behav Brain Res 205:482-487.
24. Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032-2037.
25. Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, Hayaishi O, Urade Y, Chen JF (2011) Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 31:10067-10075.
26. Lim MM, Xu J, Holtzman DM, Mach RH (2011) Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum. Neurore-port 22:489-493.
27. Linnet J, Møller A, Peterson E, Gjedde A, Doudet D (2011) Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scand J Psy-chol 52:28-34.
28. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-840.
29. Machado RB, Hipólide DC, Benedito-Silva AA, Tufik S (2004) Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res 1004:45-51.
30. McKenna BS, Dickinson DL, Orff HJ, Drummond SP (2007) The effects of one night of sleep deprivation on known-risk and ambiguous-risk decisions. J Sleep Res 16:245-252.
31. Nishino S, Mao J, Sampathkumaran R, Shelton J (1998) Increased dopami-nergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online 1:49-61.
32. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M (1993) Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266:726-731.
33. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276:1265-1268.
34. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y (2008) Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 28:8462-8469.
35. Qu WM, Xu XH, Yan MM, Wang YQ, Urade Y, Huang ZL (2010) Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 30:4382-4389.
36. Schiffer WK, Azmoodeh M, Gerasimov M, Volkow ND, Fowler JS, Dewey SL (2003) Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine. Synapse 48:35-38.
37. Schwierin B, Borbély AA, Tobler I (1996) Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300:163-171.
38. Shang Y, Haynes P, Pírez N, Harrington KI, Guo F, Pollack J, Hong P, Griffith LC, Rosbash M (2011) Imaging analysis of clock neurons reveals light buffers the wake-promoting effect of dopamine. Nat Neurosci 14:889-895.
39. Skinbjerg M, Ariano MA, Thorsell A, Heilig M, Halldin C, Innis RB, Sibley DR (2009)Arrestin3 mediates D(2) dopamine receptor internalization. Syn apse 63:621-624.
40. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A, Heilig M, Pike VW, Halldin C, Sibley DR, Innis RB (2010) D2 dopamine receptor internal-ization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuro-image 50:1402-1407.
41. Solt K, Cotten JF, Cimenser A, Wong KF, Chemali JJ, Brown EN (2011) Methylphenidate actively induces emergence from general anesthesia. Anesthesiology 115:791-803.
42. Sun W, Ginovart N, Ko F, Seeman P, Kapur S (2003) In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. Mol Pharmacol 63:456-462.
43. Thakkar MM, Winston S, McCarley RW (2003) A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci 23:4278 - 4287.
44. Thanos PK, Bermeo C, Wang GJ, Volkow ND (2011) D-cycloserine facilitates extinction of cocaine self-administration in rats. Synapse 65:938-944.
45. Tomasi D, Wang RL, Telang F, Boronikolas V, Jayne MC, Wang GJ, Fowler JS, Volkow ND (2009) Impairment of attentional networks after 1 night of sleep deprivation. Cereb Cortex 19:233-240.
46. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255-262.
47. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Schlyer DJ, Pappas N (1995) A new PET ligand for the dopamine transporter: studies in the human brain. J Nucl Med 36:2162-2168.
48. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331.
49. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121.
50. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM (2002a) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43:181-187.
51. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N (2002b) "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44:175-180.
52. Volkow ND, Wang GJ, Fowler JS, Ding YS (2005) Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1410-1415.
53. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Wong C, Ma J, Pradhan K, Tomasi D, Thanos PK, Ferré S, Jayne M (2008) Sleep deprivation decreases bindingof[11C]raclopridetodopamine D2/D3 receptorsinthe human brain. J Neurosci 28:8454-8461.
54. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Wang RL, Logan J, Wong C, Jayne M, Swanson JM (2009) Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage 45:1232-1240.
55. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with ADHD. J Neurosci 32:841-849.
56. von Zastrow M (2003) Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 74:217-224.
57. Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N (1999) Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. J Nucl Med 40:1285-1291.
58. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopami-nergic role in stimulant-induced wakefulness. J Neurosci 21:1787-1794.
59. Yoder KK, Kareken DA, Morris ED (2008) What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the stria-tum. Neurosci Lett 430:38-42.